Paul E. Dato, MD, discusses how the presence of a BRCA mutation can influence treatment selection and sequencing, supporting consideration of upfront triplet therapy intensification and planning for ...

Panelists discuss how maintenance BCG therapy and vigilant surveillance are essential for sustaining disease control in NMIBC patients, with treatment schedules and monitoring tailored to individual ...

Panelists discuss how timely identification of BCG-unresponsive NMIBC through defined response criteria enables dynamic risk stratification and guides critical decisions about escalating care to ...

MRI and focal therapy can help men with low-risk prostate cancer avoid unnecessary biopsies and extend active surveillance. The study involved 869 men, showing MRI-guided diagnosis and focal therapy ...

Among the guideline’s recommendations is the use of local low-dose vaginal estrogen as first-line therapy for GSM. The recent release of the “Genitourinary Syndrome of Menopause: AUA/SUFU [Society of ...

The study was published in JCO Oncology Practice. “I think 1 thing that people might hypothesize is that the lower citation rates of women-women papers may be due to less female physicians in these ...

Optilume DCB shows significant symptom improvement and reduced reintervention rates in urethral stricture disease over three years, with a favorable safety profile. The ROBUST III trial reported a 71% ...

Panelists discuss how evaluating a renal mass requires considering multiple factors, including patient expectations, comorbidities, life expectancy, tumor characteristics such as size and enhancement ...

An expert walks through specific actions that urologists and their teams can take before, during, and after the procedure. As with any office-based procedure, patients may have some anxiety when they ...

A panelist discusses how the differences in prostate cancer among Black men are multifactorial, including biological differences in risk alleles, social determinants of health, and limited access to ...

A panelist discusses how the ARANOTE phase 3 trial investigated darolutamide plus androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer, providing an overview of ...

Robotic prostate surgery and resource use: When prostate surgery is performed robotically, the patient typically requires a catheter for about 1 week. This leads to increased resource utilization, ...